erlotinib hydrochloride has been researched along with Aneuploid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barberis, M; Catania, C; Conforti, F; de Marinis, F; De Pas, T; Lazzari, C; Noberasco, C; Spitaleri, G; Stufano, V; Toffalorio, F; Vecchio, F | 1 |
Couzin, J | 1 |
2 other study(ies) available for erlotinib hydrochloride and Aneuploid
Article | Year |
---|---|
Erlotinib efficacy in NSCLC patients with high polysomy of chromosome 7 and EGFR/KRas wild-type tumors.
Topics: Aneuploidy; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chromosomes, Human, Pair 7; Cohort Studies; Disease-Free Survival; ErbB Receptors; Erlotinib Hydrochloride; Female; Genes, ras; Humans; Lung Neoplasms; Male; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Quinazolines; ras Proteins | 2015 |
Cancer research. Fake data, but could the idea still be right?
Topics: Aneuploidy; Antineoplastic Agents; Controlled Clinical Trials as Topic; Erlotinib Hydrochloride; Genetic Markers; Humans; Loss of Heterozygosity; Mouth Diseases; Mouth Neoplasms; Quinazolines; Risk Factors; Scientific Misconduct | 2006 |